S. Mannan

Efficacy and safety of high infusion rate IVIG in CIDP

V. Bril, C. Barnett, H. Katzberg, 2020, Muscle & nerve.

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

Prospective study of stress, depression and personality in myasthenia gravis relapses

V. Bril, C. Barnett, A. Abraham, 2020, BMC Neurology.

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Denny J. Padgett, Adam L. Comer, Yi-Chung Lee, 2023, The Lancet Neurology.

Chronic stress, depression and personality type in patients with myasthenia gravis

V. Bril, C. Barnett, A. Abraham, 2020, European journal of neurology.